Sweden· SE-20160527000021
CELSENTRI 25 mg Filmdragerad tablett
A medicinal product containing maraviroc, registered in Sweden by ViiV Healthcare BV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Maraviroc
- Manufacturer
- ViiV Healthcare BV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20160527000021
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maraviroc in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCelsentri 25 mgViiV Healthcare
- CzechiaCELSENTRIViiV Healthcare BV, Amersfoort
- FinlandCELSENTRIViiV Healthcare BV
- FranceCELSENTRI 25 mg, comprimé pelliculéVIIV HEALTHCARE UK (ROYAUME-UNI)
- IrelandCelsentri 25 mg Film-coated tabletViiV Healthcare BV
- IcelandCelsentriViiV Healthcare BV
- PolandCelsentriViiV Healthcare BV
- United StatesMaravirocCamber Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Maraviroc
- Germany · Maraviroc, Maraviroc Amarox
- Spain · Maraviroc Tarbis, Maraviroc Waymade
- France · Maraviroc, Maraviroc Amarox
- United Kingdom (Northern Ireland) · Maraviroc Amarox Limited, Maraviroc Waymade
- Iceland · Celsentri
- Italy · Maraviroc Waymade
- Liechtenstein · Celsentri
- Netherlands · Maraviroc, Maraviroc Amarox
- Norway · Celsentri
- Portugal · Maraviroc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1573fd08-5769-4694-92ac-ef732c38c52a GET /v1/drugs/1573fd08-5769-4694-92ac-ef732c38c52a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20160527000021",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20160527000021",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/celsentri-epar-product-information_sv.pdf"
}See everything about maraviroc.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.